Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-25

Clinical Trial Update: Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on Accelerated Hypofractionated 1 Week Radiotherapy in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Zagazig University | Conditions: Breast Cancer Radiotherapy | Phase 3 | Status: COMPLETED